Skip to content

Heading in football: impact on neural blood biomarkers

Heading in football: impact on neural blood biomarkers - HEADLINE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53582
Enrollment
280
Registered
2023-07-26
Start date
2024-08-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain damage Neurodegeneration

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Member of the KNVB - 18 years or older - Male - Self-reported fitness to play 70-90 minutes

Exclusion criteria

Exclusion criteria: - Sustained a head injury in the last year - History or current neurological condition - Regular participation in other contact sports (e.g. rugby, American football, ice hockey, fighting sports) - (Former) military personnel with a history of fighting/blast exposure

Design outcomes

Primary

MeasureTime frame
The main study parameter is the change in concentration of neurofilament light after playing a football match with naturalistic heading exposure.

Secondary

MeasureTime frame
The secondary study parameters are the change in concentration of GFAP, p-Tau, S100B, NSE and beta-synuclein in blood after playing a football match with naturalistic heading exposure. Other study parameters are demographic variables, medical history, heading characteristics, exercise intensity, and genetic risk factors for neurodegenerative disease.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 3, 2026